Xencor | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
AbbVie USD 3.32B 291M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Amgen USD 1.81B 44M 2024-03
Arrowhead Research USD 24.64M 1.54M 2024-03
AstraZeneca USD 3.91B 194M 2023-09
Biogen USD 581.5M 27M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Cytokinetics USD 45.5M 1.39M 2024-03
GlaxoSmithKline GBP 2.09B 500M 2024-03
J&J USD 5.06B 753M 2024-03
Merck USD 2.48B 268M 2024-03
Pfizer USD 3.5B 976M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Roche Holding CHF 6.51B 26M 2023-06



Xencor Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jun 2024.